Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Profound Medical Corp (PROF)

Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Profound Medical Corp 2400 SKYMARK AVENUE UNIT 6 MISSISSAUGA A6 L4W 5K5 CAN

www.profoundmedical.com P: 64-7476-1350 F: 647-847-3739

Description:

Profound Medical Corp. is a medical technology company. It is focused on a therapeutics platform which provides the precision of real-time Magnetic Resonance Imaging technology for the incision-free ablation of diseased tissue. The company principally commercialized the TULSA-PRO(R) and Sonalleve(R) platforms. Profound Medical Corp. is based in Mississauga, Canada.

Key Statistics

Overview:

Market Capitalization, $K 179,553
Enterprise Value, $K 160,443
Shares Outstanding, K 24,429
Annual Sales, $ 7,200 K
Annual Net Income, $ -28,570 K
Last Quarter Sales, $ 2,010 K
Last Quarter Net Income, $ -8,910 K
EBIT, $ -28,620 K
EBITDA, $ -27,470 K
60-Month Beta 0.84
% of Insider Shareholders 1.52%
% of Institutional Shareholders 47.86%
Float, K 24,058
% Float 98.48%
Short Volume Ratio 0.52

Growth:

1-Year Return -41.45%
3-Year Return -63.55%
5-Year Return 9.38%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.42 on 03/07/24
Latest Earnings Date 05/09/24 [AMC]
Earnings Per Share ttm -1.35
EPS Growth vs. Prev Qtr -61.54%
EPS Growth vs. Prev Year 8.70%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 10/16/19

PROF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -70.18%
Return-on-Assets % -53.80%
Profit Margin % -396.81%
Debt/Equity 0.23
Price/Sales 25.28
Price/Cash Flow N/A
Price/Book 5.83
Book Value/Share 1.28
Interest Coverage -357.75
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar